Trends for ejaculatory sparing and minimally invasive surgical treatments adoption for lower urinary tract symptoms related to BPH in Italy: screenshot from the Italian society of urology (SIU) benign research network
Rattachement africain : it, tr. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Minimally invasive surgical treatments (MISTs) for benign prostatic hyperplasia (BPH) are increasingly adopted due to fewer complications and better preservation of ejaculatory function. However, real-world data on patient selection and clinical application in Italy remain scarce. METHODS: Patients undergoing Aquablation, Rezum, iTIND, TPLA, or PUL from October 2022 to December 2024 were prospectively enrolled by 15 Italian centers in the SIU Research Network. Baseline clinical, anatomical, and functional data were collected via a secure digital platform. Data were recorded using standardized electronic case report forms, and patient-reported outcomes were gathered through validated questionnaires administered at baseline and during follow-up. RESULTS: A total of 312 patients were enrolled: 30 (9.6%) Aquablation, 97 (31.1%) Rezum, 49 (15.7%) iTIND, 108 (34.6%) TPLA, and 28 (9.0%) PUL. iTIND patients were the youngest (median age 47, IQR 42-57), had the lowest prostate volume (30 mL, IQR 27.5-40), lowest comorbidity scores, and poorest Qmax (6.2 mL/s, IQR 5-8). Aquablation and TPLA were adopted for larger prostates (70 mL, IQR 50-80 and 67 mL, IQR 45-85, respectively). Median lobe was most frequent in Rezum (56.7%) patients. PUL patients had the lowest post-void residual (20 mL, IQR 5-60). Rezum and TPLA patients reported better ejaculatory function (P<0.02), while iTIND patients showed the highest dysfunction (P<0.05). Baseline QoL scores were comparable across groups. CONCLUSIONS: This interim analysis shows that MIST adoption in Italy is influenced by prostate size, age, comorbidities, and functional profiles. The findings describe baseline selection patterns only, with postoperative outcomes to be reported in future analyses.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Trends for ejaculatory sparing and minimally invasive surgical treatments adoption for lower urinary tract symptoms related to BPH in Italy: screenshot from the Italian society of urology (SIU) benign research network
- Date Crossref
- 01/02/2026
- Éditeur
- Edizioni Minerva Medica
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Florence Unit of Oncologic Minimally Invasive Urology and Andrology pays non établi dans la noticeUniversité ou école supérieure
-
Ospedale San Luigi Gonzaga pays non établi dans la noticeÉtablissement de santé
-
University of Turin Department of Oncology pays non établi dans la noticeUniversité ou école supérieure
-
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda pays non établi dans la noticeÉtablissement de santé
-
University of Catania Unit of Urological Minimally Invasive Robotic Surgery and Renal Transplantation pays non établi dans la noticeUniversité ou école supérieure
-
Biruni University Department of Urology pays non établi dans la noticeUniversité ou école supérieure
-
Azienda Ospedaliero-Universitaria Careggi pays non établi dans la noticeÉtablissement de santé
-
University of Perugia Department of General and Oncologic Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Azienda Ospedaliera di Perugia pays non établi dans la noticeÉtablissement de santé
-
Azienda Ospedaliero-Universitaria delle Marche pays non établi dans la noticeÉtablissement de santé
-
Azienda Ospedaliera Sant'Andrea pays non établi dans la noticeÉtablissement de santé
-
Vita-Salute San Raffaele University Vita-Salute pays non établi dans la noticeUniversité ou école supérieure
Unit of Oncologic Minimally Invasive Urology and Andrology — University of Florence, Ospedale San Luigi Gonzaga et Department of Oncology — University of Turin, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.